MedTrace Logo

Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)

NCT01444586 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2293

Last updated 2017-01-23

No results posted yet for this study

Summary

This is a local, prospective, multicenter, non-interventional, observational study. Primary objective is to describe how in "real life" thromboprophylaxis is carried out after the discharge from a hospital in the patients who undergo elective knee and hip replacement and who receive Xarelto during hospitalization.

Conditions

  • Arthroplasty, Replacement, Hip
  • Arthroplasty, Replacement, Knee

Interventions

DRUG

Rivaroxaban (Xarelto, BAY59-7939)

The patients will be treated according to the routine practice. All the patients meeting the criteria of inclusion and exclusion to whom administration of Xarelto is indicated are fit for participation in this non-interventional study.

Sponsors & Collaborators

  • Janssen Research & Development, LLC

    collaborator INDUSTRY

  • Bayer

    lead INDUSTRY

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-08-31
Completion
2014-07-31

Countries

  • Russia

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01444586 on ClinicalTrials.gov